logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10845366 B1

PDFFull Text
Date of Patent:
Nov. 24, 2020

Filed:

Oct. 26, 2018

Predictive markers for polyamine inhibitor cancer therapies

Applicant:

Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);

Inventors:

Eugene Gerner, Tucson, AZ (US);

Edwin Paz, Durham, NC (US);

Bonnie Lafleur, Tucson, AZ (US);

Jenaro Garcia-Huidobro, Tucson, AZ (US);

Assignee:

ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA, Tucson, AZ (US);

Attorney:

Parker Highlander PLLC

Primary Examiner:

Jeffrey S Lundgren

Assistant Examiner:

Michael J Schmitt

Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61K 45/06 (2006.01); A61K 31/192 (2006.01); A61K 31/196 (2006.01); A61K 31/198 (2006.01); A61K 31/616 (2006.01); A61K 31/635 (2006.01); C12Q 1/6886 (2018.01); C12Q 1/18 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57496 (2013.01); A61K 31/192 (2013.01); A61K 31/196 (2013.01); A61K 31/198 (2013.01); A61K 31/616 (2013.01); A61K 31/635 (2013.01); A61K 45/06 (2013.01); C12Q 1/18 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57492 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01); G01N 2333/4703 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention relates to therapeutic methods and medical uses comprising the identification and use of cancer marker surrogates for increased polyamine expression. These markers may be used to identify patients who may be treated for diseases and disorders that are susceptible to polyamine synthesis inhibitors, and they can also be used to monitor therapeutic responses when such agents are used.

Find Patent Forward Citations

Gerner, Eugene. (2020). Predictive markers for polyamine inhibitor cancer therapies (U.S. Patent No. 10845366). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10845366

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…